longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Electra Therapeutics

ETRA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
All ShareholdersInstitutional HoldersInsiders

All Shareholders

Shareholder Type

  • Public and others47.65%
  • VC/PE firms32.30%
  • Hedge funds8.70%
  • Private companies6.05%
  • Others5.29%

Major Shareholders

Major Shareholders Latest
Shareholder
OrbiMed Advisors LLC
10.97%6.89M--+6.89M09/25/2026
Westlake Village BioPartners
10.11%6.35M--+6.35M09/21/2026
Redmile Group, LLC
8.70%5.46M--+5.46M09/21/2026
EQT Life Sciences
6.05%3.80M--+3.80M09/21/2026
Lsp 7 Cooperatief U.A.
6.05%3.80M--+3.80M09/21/2026
New Leaf Venture Partners, LLC
5.18%3.25M--+3.25M09/18/2026
Sanofi
3.92%2.46M--+2.46M09/18/2026
Quehuong DongPresident, CEO & Director
0.73%455.48K--+455.48K09/21/2026
Nancy StaglianoIndependent Chair
0.41%255.64K--+255.64K09/21/2026
Graham ParryChief Scientific Officer
0.14%85.50K--+85.50K09/21/2026
Gary KoeChief Technology Officer
0.10%63.66K--+63.66K09/21/2026
Matthew FustIndependent Director
0.00%0.00--+009/18/2026
Kim-Hien DaoChief Medical Officer
0.00%0.00--+009/18/2026